SLC25A32 promotes malignant progression of glioblastoma by activating PI3K-AKT signaling pathway.
Xue Z, Wang J, Wang Z, Liu J, Zhao J, Liu X, Zhang Y, Liu G, Zhao Z, Li W, Zhang Q, Li X, Huang B, Wang X.
Xue Z, et al. Among authors: wang x, wang j, wang z.
BMC Cancer. 2023 Jun 26;23(1):589. doi: 10.1186/s12885-023-11097-6.
BMC Cancer. 2023.
PMID: 37365560
Free PMC article.